We
report a promising strategy based on chitosan (CS) hydrogels
and dual temperature- and pH-responsive poly(N-isopropylacrylamide-co-methacrylic acid) (PNIPAM-co-MAA) microgels
to facilitate release of a model drug, moxifloxacin (MFX). In this
protocol, first, the microgels were prepared using a free radical
copolymerization method, and subsequently, these carboxyl-group-rich
soft particles were incorporated inside the hydrogel matrix using
an EDC-NHS amidation method. Interestingly, the resulting microgel-embedded
hydrogel composites (MG-HG) acting as a double barrier system largely
reduced the drug release rate and prolonged the delivery time for
up to 68 h, which was significantly longer than that obtained using
microgels or hydrogels alone (20 h). On account of the dual-responsive
features of the embedded microgels and the variation of water-solubility
of drug molecules as a function of pH, MFX could be released in a
controllable manner by regulating the temperature and pH of the delivery
medium. The release kinetics followed a Korsmeyer-Peppas model, and
the drug delivery mechanism was described by Fickian diffusion. Both
the gel precursors and the hydrogel composites exhibited low cytotoxicity
against mammalian cell lines (HeLa and HEK-293) and no deleterious
hemolytic activity up to a certain higher concentration, indicating
excellent biocompatibility of the materials. Thus, the unprecedented
combination of modularity of physical properties caused by soft particle
entrapment, unique macromolecular architecture, biocompatibility,
and the general utility of the stimuli-responsive polymers offers
a great promise to use these composite materials in drug delivery
applications.